Roles for TAB1 in regulating the IL-1-dependent phosphorylation of the TAB3 regulatory subunit and activity of the TAK1 complex

Heidi Mendoza, David G. Campbell, Kerry Burness, James Hastie, Natalia Ronkina, Jae-Hyuck Shim, J. Simon C. Arthur, Roger J. Davis, Matthias Gaestel, Gary L. Johnson, Sankar Ghosh, Philip Cohen

    Research output: Contribution to journalArticlepeer-review

    50 Citations (Scopus)

    Abstract

    The protein kinase TAK1 (transforming growth factor-beta-activated kinase 1), which has been implicated in the activation of MAPK (mitogen-activated protein kinase) cascades and the production of inflammatory mediators by LPS (lipopolysaccharide), IL-1 (interleukin 1) and TNF (tumour necrosis factor), comprises the catalytic subunit complexed to the regulatory subunits, termed TAB (TAK1-binding subunit) 1 and either TAB2 or TAB3. We have previously identified a feedback-control mechanism by which p38 alpha MAPK down-regulates TAK1 and showed that p38 alpha MAPK phosphorylates TAB1 at Ser(423) and Thr(431). In the present study, we identified two IL-1-stimulated phosphorylation sites on TAB2 (Ser(372) and Ser(524)) and three on TAB3 (Ser(60), Thr(404) and Ser(506)) in human IL-1R cells [HEK-293 (human embryonic kidney) cells that stably express the IL-1 receptor] and MEFs (mouse embryonic fibroblasts). Ser(372) and Ser(524) of TAB2 are not phosphorylated by pathways dependent on p38 alpha/beta MAPKs, ERK1/2 (extracellular- signal -regulated kinase 1/2) and JNK1/2 (c-Jun N-terminal kinase 1/2). In contrast, Ser(60) and Thr(404) of TAB3 appear to be phosphorylated directly by p38 alpha MAPK, whereas Ser(506) is phosphorylated by MAPKAP-K2/MAPKAPK-K3 (MAPK-activated protein kinase 2 and 3), which are protein kinases activated by p38 alpha MAPK. Studies using TAB1(-/-) MEFs indicate important roles for TAB1 in recruiting p38 alpha MAPK to the TAK1 complex for the phosphorylation of TAB3 at Ser(60) and Thr(404) and in inhibiting the dephosphorylation of TAB3 at Ser(506). TAB1 is also required to induce TAK1 catalytic activity, since neither IL-1 nor TNF alpha was able to stimulate detectable TAK1 activity in TAB1(-/-) MEFs. Surprisingly, the IL-1 and TNF alpha-stimulated activation of MAPK cascades and I kappa B (inhibitor of nuclear factor kappa B) kinases were similar in TAB1(-/-), MEKK3(-/-) [MAPK/ERK (extracellular-signal-regulated kinase) kinase kinase 3] and wild-type MEFs, suggesting that another MAP3K (MAPK kinase kinase) may mediate the IL-1/TNF alpha-induced activation of these signalling pathways in TAB1(-/-) and MEKK3(-/-) MEFs.

    Original languageEnglish
    Pages (from-to)711-722
    Number of pages12
    JournalBiochemical Journal
    Volume409
    DOIs
    Publication statusPublished - 1 Feb 2008

    Keywords

    • interleukin-1 (IL-1)
    • mitogen-activated protein kinase (MAPK) nuclear factor kappa B (NF-kappa B)
    • TAK1(transforming growth factor beta-activated protein kinase 1-bnding protein 1 (TAB1)
    • transforming growth factor beta-activated protein kinase 1(TAK1)
    • tumour necrosis factor alpha (TNF alpha)
    • TUMOR-NECROSIS-FACTOR
    • KINASE KINASE KINASE
    • KAPPA-B ACTIVATION
    • P38 MAP KINASE
    • IN-VIVO
    • DEPENDENT ACTIVATION
    • SIGNALING PATHWAYS
    • DEATH PATHWAY
    • PROTEIN
    • BIOSYNTHESIS

    Cite this